CA2005060A1 - Tnf peptides - Google Patents

Tnf peptides

Info

Publication number
CA2005060A1
CA2005060A1 CA002005060A CA2005060A CA2005060A1 CA 2005060 A1 CA2005060 A1 CA 2005060A1 CA 002005060 A CA002005060 A CA 002005060A CA 2005060 A CA2005060 A CA 2005060A CA 2005060 A1 CA2005060 A1 CA 2005060A1
Authority
CA
Canada
Prior art keywords
val
tyr
ser
peptide
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002005060A
Other languages
English (en)
French (fr)
Inventor
Nigel Walker
Hans-Joachim Boehm
Lothar Daum
Andreas Haupt
Bernhard Schmied
Johann-Christian Zechel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CA2005060A1 publication Critical patent/CA2005060A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002005060A 1988-12-12 1989-12-11 Tnf peptides Abandoned CA2005060A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3841761A DE3841761A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide
DEP3841761.8 1988-12-12

Publications (1)

Publication Number Publication Date
CA2005060A1 true CA2005060A1 (en) 1990-06-12

Family

ID=6368956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005060A Abandoned CA2005060A1 (en) 1988-12-12 1989-12-11 Tnf peptides

Country Status (5)

Country Link
EP (1) EP0447465A1 (de)
JP (1) JPH04502315A (de)
CA (1) CA2005060A1 (de)
DE (1) DE3841761A1 (de)
WO (1) WO1990006946A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587457A (en) * 1990-03-12 1996-12-24 Peptide Technology Limited Neutrophil stimulating peptides
US6375928B1 (en) 1990-03-12 2002-04-23 Peptech Limited Neutrophil stimulating peptides

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521918A4 (en) * 1990-03-19 1993-05-05 Peptide Technology Ltd Anti-tumour peptides
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6107273A (en) * 1995-01-24 2000-08-22 Thomas Jefferson University Tumor necrosis factor inhibitors
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
WO2005084198A2 (en) 2004-02-27 2005-09-15 Vaxconsulting Peptides of il1 beta and tnf alpha and method of treatment using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305615A1 (de) * 1987-09-03 1989-03-08 Immunetech Pharmaceuticals, Inc. Peptidantagonisten für C5a-Anaphylotoxin
WO1987007614A1 (en) * 1986-06-03 1987-12-17 Pert Candace B Small peptides which inhibit binding to t-4 receptors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587457A (en) * 1990-03-12 1996-12-24 Peptide Technology Limited Neutrophil stimulating peptides
US6375928B1 (en) 1990-03-12 2002-04-23 Peptech Limited Neutrophil stimulating peptides

Also Published As

Publication number Publication date
DE3841761A1 (de) 1990-06-13
WO1990006946A1 (de) 1990-06-28
JPH04502315A (ja) 1992-04-23
EP0447465A1 (de) 1991-09-25

Similar Documents

Publication Publication Date Title
RU2132334C1 (ru) Аналог долостатина
US20080090760A2 (en) Compositions and Methods for Inhibiting Cellular Proliferation
JPH03118330A (ja) フイブリノーゲンレセプター拮抗剤
KR20110125235A (ko) 뉴로펩타이드 ｙ 수용체 결합성 화합물을 포함하는 세포독성 접합체
JPH07121956B2 (ja) ブラジキニンアンタゴニスト作用を有するペプチド
JP2010265271A (ja) ソマトスタチンベクター
KR100286242B1 (ko) 돌라스타틴 유도체
JPH03118331A (ja) 環状フイブリノーゲンレセプター拮抗薬
JP2599947B2 (ja) ペプチド化合物
CA2005058A1 (en) Tnf peptides
CA2005060A1 (en) Tnf peptides
CA2005059A1 (en) Tnf peptides
US4473555A (en) Nona- and dodecapeptides for augmenting natural killer cell activity
CA2005050A1 (en) Tnf peptides
CA2005051A1 (en) Tnf peptides
CA2039880A1 (en) Somatostatin analogues
CA2005061A1 (en) Tnf peptides
CA1340964C (en) Crf analogs
CA2005281A1 (en) Tnf peptides
CA2005052A1 (en) Tnf peptides
CA2005057A1 (en) Tnf peptides
JPH0687891A (ja) ブラジキニン−アンタゴニスト活性を有するペプチド化合物
CA2005056A1 (en) Tnf peptides
EP0487238A3 (de) Verfahren zur Hemmung der Plättchenadhäsion auf dem Kollagen
JP2004534736A (ja) 抗血管形成ペプチド

Legal Events

Date Code Title Description
FZDE Dead